On-Line Pharmaceutical Database Reference
Page 2 of 4
REQUEST FOR INFORMATION
On-Line Pharmaceutical Reference database
Description
1.1 The Department of Veterans Affairs, in support of the Facilities Management Service, is seeking information on how an interested contractor could provide NCO 4 s VA Medical Centers and CBOC s with an On-Line Pharmaceutical Reference database.
1.2 THIS IS A REQUEST FOR INFORMATION (RFI) ONLY. This RFI is issued solely for information and planning purposes it does not constitute a Request for Quote (RFQ) or a promise to issue an RFQ in the future. This RFI does not commit the Government to contract for any supply or service whatsoever. Further, the VHA is not at this time seeking proposals and will not accept unsolicited proposals. Responders are advised that the Veterans Health Administration (VHA) will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party s expense. Not responding to this RFI does not preclude participation in any future RFQ, if any is issued. It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement.
Background.
The U.S. Health Care System has transitioned from hardcopy medical references to electronic reference databases. Staff in VISN 4 require online web access to searchable medical reference databases for quick and easy retrieval of up to date and evidence based medical information for health care providers and patients. Electronic medical references reduce the need for multiple individual copies of expensive resources, and eliminates the need to periodically update multiple hard copies (which can be a source of errors). The electronic method provides a more efficient manner of retrieving medically necessary information to meet the clinical mission of serving Veterans within the VISN 4.
VISN 4 currently utilizes Clinical Pharmacology, which is a real-time, web-based drug information software solution.
3.0 Responses
3.1 Interested parties are requested to respond to this RFI with a Capabilities Statement. Please include your Socioeconomic Status (SB, LB, SDVOSB, etc.) as attested by your SAM Registration. If you have this product available via a GSA contract, please provide your GSA Schedule # with your response to this RFI.
3.2 Capabilities Statements should include the ability to provide access to the following content listed below:
Drug Monographs shall include at a minimum the following information:
Adult and Pediatric monograph
Description/Classification of Drug
Mechanism of Action
Pharmacokinetic/Pharmacodynamics
Administration Instructions
Monitoring Parameters
Contraindications/Precautions
Pregnancy/Breastfeeding
Interactions
Adverse Reactions
How Drug Supplied
US and Global Drug Names
Reference Sources
Reports shall include
Drug interaction reports including information that may impact lifestyle (caffeine, enteral feedings, ethanol, food, grapefruit juice and tobacco).
Product Comparison
IV Compatibility
Adverse Reaction
Clinical Comparison
Patent Report
Drug Lists shall include
Drug Monograph
Investigational Drug Monograph
Complementary and Alternative Medicine Monograph
Beers Drug List
Combination Chemotherapy Regimen
Products with REM
Products with MedGuides
Boxed warnings
Interaction with Grapefruit
Confused Drug Names
Not Recommended for Splitting
Package Require Dilution
Do Not Crush
ISMP High Alert Medications for Acute and Community/Ambulatory
Narrow Therapeutic Index
Patient Education Information shall include
MedCounselor education sheets
Discharge instructions by condition or drug product
Mosby Nursing Consult
Resources/Links shall include access to
Manufacturer contact information
Laboratory reference values
Clinical Calculator to include general dosing, BSA, emergency medication calculation, carboplatin, aminoglycoside, vancomycin, heparin, phenytoin and opioid medication conversion.
Drug class overview
Vaccine Information Sheets (VIS)
Natural Medicine Database
Pharmacist s Letter
Toxicology (ToxEd)
Drug Identifier
Searchable by imprint/marking with options for color, shape, scoring and dosage form. Search results provide drug name and dosage strength, product picture, manufacturer, NDC, active and inactive ingredients.
Find Option for Drug Information by the following:
Indication, Contraindication/Precautions, Adverse Reaction, Drug Classification, NDC, Manufacturer, Classification by Product and Multi-Criteria.
3.3 Capabilities Statements must be in Microsoft Word for Office 2000 compatible format and are due by April 23, 2018 at 12:00 PM EST. Responses shall be limited to 10 pages for Section 2 and submitted via e-mail only to derrick.maruski2@va.gov. Proprietary information, if any, should be minimized and MUST BE CLEARLY MARKED. To aid the Government, please segregate proprietary information. Please be advised that all submissions become Government property and will not be returned.
4.0 Questions
Questions regarding this announcement shall be submitted in writing by e-mail to the Contracting Officer, email address. Verbal questions will NOT be accepted. Questions will be answered by posting answers to the RFI submittal website; accordingly, questions shall NOT contain proprietary or classified information. The Government does not guarantee that questions received after April 20, 2018 at 12:00 PM EST will be answered.
5.0 Summary
THIS IS A REQUEST FOR INFORMATION (RFI) ONLY to identify sources that can provide On-Line Pharmaceutical Reference database Services. The information provided in the RFI is subject to change and is not binding on the Government. The VHA has not made a commitment to procure any of the items discussed, and release of this RFI should not be construed as such a commitment or as authorization to incur cost for which reimbursement would be required or sought. All submissions become Government property and will not be returned.
End of Document
Derrick L. Maruski
derrick.maruski2@va.gov
Derrick.Maruski2@va.gov
